Meet Our Experts

Kevin Coker, JD, MPH, MS

CEO & Co-Founder
Positions & Honors
Contributions to Science
Additional Information
Originally From:
Little Rock, Arkansas
Fun Fact:
Kevin helped patients get access to lifesaving antiretroviral drugs in Africa twenty years ago and it changed his life forever.

Kevin Coker is the Co-Founder and CEO of Proxima Clinical Research, a contract research organization that serves the emerging drug and medical device industries. 

Over his career, Mr. Coker has served in a number of executive roles. Previously, he was CEO and Director of MolecularMatch, a software company dedicated to helping laboratories interpret next generation sequencing tests for clinical practice. He served as the Vice President and Oncology Franchise Lead for Worldwide Clinical Trials, a global CRO working in over 50 countries, and the Vice President of Research for McKesson/US Oncology. Mr. Coker is currently a Board Director for Volumetric, a 3D bioprinting company focused on making the world’s first 3D printed liver and is an advisor for Bioverge, an investment platform focused on life science companies.

Mr. Coker received a B.S. in Biology from the University of Central Arkansas, a M.S. in Pathology from the University of Arkansas for Medical Sciences, and J.D. and M.P.H. degrees from Case Western Reserve University. He is as a certified clinical molecular biologist CLSp(MB) and Regulatory Affairs certified RAC (US). He is the former Chair of the Ethics Committee for Regulatory Affairs Professional Society (RAPS) as well as past Board Member and served as an Assistant Attorney General for the State of Arkansas. He has been involved in over hundred clinical trials for pharmaceutical companies pursuing marketing indications and been involved in dozens of regulatory submissions for both biotech and medical device companies.


University of Central Arkansas: Biology, B.S.

University of Arkansas for Medical Sciences: Pathology, M.S.

Case Western Reserve University School of Medicine: Epidemiology, M.P.H.

Case Western Reserve University School of Law: Health Law, Litigation, J.D.

Positions & Honors

Proxima Clinical Research, Inc., Houston, Texas
Cofounder, CEO

MolecularMatch, Inc., Houston, Texas

Worldwide Clinical Trials, Inc., King of Prussia, PA
Vice President Oncology

McKesson, Inc., Woodlands, Texas
Vice President Research Services

The US Oncology Network, Inc., Woodlands, Texas (acquired by McKesson)
Vice President Research Services

Rocky Mountain Cancer Centers, LLC, Denver, CO (a Division of US Oncology)
Director of Research Operations

University of Arkansas for Medical Sciences, Little Rock, AR
Director of Operations

Attorney General of State of Arkansas, Little Rock, AR
Asst. Attorney General

University of Arkansas for Medical Sciences, Little Rock, AR
Research Associate

Contributions to Science

Mr. Coker has spent the last twenty years in the clinical research industry. He helped coordinate the effort to fund the Clinical and Translational Science Award for the University of Arkansas for Medical Sciences over two decades ago - still the largest single federal award to the university. There he managed a clinical research unit and oversaw research in areas such as:

  1. Cardiovascular Medicine
  2. Cognitive Neuroscience
  3. Diabetes
  4. Metabolic Disorders
  5. Nutrition
  6. Substance Abuse
  7. Sleep Disorders

Mr. Coker has spent a significant portion of his career in the oncology space and has had personal responsibility in areas such as:

  1. Acute Lymphoblastic Leukemia (ALL)
  2. Acute Myeloid Leukemia (AML)
  3. Breast cancer
  4. Carcinoid Tumor
  5. Chronic Lymphocytic Leukemia (CLL)
  6. Chronic Myelogenous Leukemia (CML)
  7. Colorectal Cancer
  8. Gastric (Stomach) Cancer
  9. Gastrointestinal Stromal Tumors (GIST)
  10. Liver Cancer
  11. Lung Cancer
  12. Lymphoma
  13. Melanoma
  14. Non-Hodgkin Lymphoma
  15. Non-Small Cell Lung Cancer
  16. Ovarian Cancer
  17. Pancreatic Cancer
  18. Prostate Cancer
  19. Renal Cell Cancer
  20. Wilms Tumor  

In addition to these areas Mr. Coker has frequently worked in the in vitro diagnostic area including the next generation sequencing space.

Additional Information